Literature DB >> 8461239

Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.

M Koizumi1, T Watari, K Hirabayashi.   

Abstract

Thallium-201 (201Tl) scintigraphy has been used in the evaluation of thyroid neoplasm. Even though several authors have shown the usefulness of 201Tl scintigraphy in evaluating recurrent tumor of medullary thyroid cancer, the number of reports on primary thyroid cancer is limited. We presented a case of medullary thyroid cancer which showed 201Tl uptake in both early and delayed scans. This case had normal serum levels of calcitonin and carcinoembryonic antigen.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461239     DOI： 10.1007/bf03164793

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN： 0914-7187            Impact factor:   2.668


  13 in total

1.  Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.

Authors:  C A Hoefnagel; C C Delprat; H R Marcuse; J J de Vijlder
Journal:  J Nucl Med       Date:  1986-12       Impact factor: 10.057

2.  Scintigraphic portrayal of the syndrome of multiple endocrine neoplasia type-2B.

Authors:  J J Yobbagy; R Levatter; J C Sisson; B L Shulkin; T Polley
Journal:  Clin Nucl Med       Date:  1988-06       Impact factor: 7.794

3.  Early and delayed thallium 201 imaging. Diagnosis of patients with cold thyroid nodules.

Authors:  R P Bleichrodt; A Vermey; D A Piers; Z J de Langen
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

4.  Imaging of medullary thyroid cancer with 131I-MIBG.

Authors:  K Endo; K Shiomi; K Kasagi; J Konishi; K Torizuka; K Nakao; H Tanimura
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

5.  Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.

Authors:  T E Hilditch; J M Connell; A T Elliot; T Murray; N S Reed
Journal:  J Nucl Med       Date:  1986-07       Impact factor: 10.057

6.  Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy.

Authors:  N B Arnstein; J E Juni; J C Sisson; R V Lloyd; N W Thompson
Journal:  J Nucl Med       Date:  1986-10       Impact factor: 10.057

7.  Comparison of Tl-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumor: concise communication.

Authors:  O Senga; M Miyakawa; H Shirota; M Makiuchi; K Yano; M Miyazawa; M Takizawa
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

8.  A new imaging agent for medullary carcinoma of the thyroid.

Authors:  H Ohta; K Yamamoto; K Endo; T Mori; D Hamanaka; A Shimazu; K Ikekubo; K Makimoto; Y Iida; J Konishi
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

9.  Clinical application of 201Tl scintigraphy in patients with cold thyroid nodules.

Authors:  N Tonami; H Bunko; T Michigishi; A Kuwajima; K Hisada
Journal:  Clin Nucl Med       Date:  1978-06       Impact factor: 7.794

10.  Radiotracer uptake in medullary carcinoma of the thyroid.

Authors:  K L Parthasarathy; K Shimaoka; S P Bakshi; M S Razack
Journal:  Clin Nucl Med       Date:  1980-02       Impact factor: 7.794
View more
  1 in total

1.  Scintigraphic detection of recurrence of medullary thyroid cancer.

Authors:  M Koizumi; Y Yamada; E Nomura; M Amano; Y Okajima; H Okizuka; K Yamada; S Sawano; T Kitahara; T Yamashita
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.